Pembrolizumab plus lenvatinib enabling cytoreductive nephrectomy in metastatic chromophobe renal cell carcinoma: a case report
We report the case of a 65-year-old woman diagnosed with metastatic chromophobe renal cell carcinoma, classified as intermediate risk according to IMDC criteria, who presented with a large left renal mass, para-aortic lymphadenopathy and bilateral pulmonary nodules. First-line treatment with pembrolizumab plus lenvatin...